These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 26810437)

  • 1. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
    Freeman ML; Lederman MM; Gianella S
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
    Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximity of Cytomegalovirus-Specific CD8
    Heath JJ; Fudge NJ; Gallant ME; Grant MD
    Front Immunol; 2018; 9():201. PubMed ID: 29527205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
    Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
    Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.
    Christensen-Quick A; Vanpouille C; Lisco A; Gianella S
    AIDS Res Hum Retroviruses; 2017 Nov; 33(S1):S23-S30. PubMed ID: 29140108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus, aging, and HIV: a perfect storm.
    Barrett L; Fowke KR; Grant MD
    AIDS Rev; 2012; 14(3):159-67. PubMed ID: 22833059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV.
    Royston L; Isnard S; Lin J; Routy JP
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART.
    Dan JM; Massanella M; Smith DM; Spina CA; Schrier R; Daar ES; Dube MP; Morris SR; Gianella S
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):133-7. PubMed ID: 26818740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.
    Poizot-Martin I; Allavena C; Duvivier C; Cano CE; Guillouet de Salvador F; Rey D; Dellamonica P; Cuzin L; Cheret A; Hoen B;
    PLoS One; 2016; 11(11):e0165774. PubMed ID: 27824907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus-specific T-cells are associated with immune senescence, but not with systemic inflammation, in people living with HIV.
    Ballegaard V; Brændstrup P; Pedersen KK; Kirkby N; Stryhn A; Ryder LP; Gerstoft J; Nielsen SD
    Sci Rep; 2018 Feb; 8(1):3778. PubMed ID: 29491459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants.
    Scott ZA; Chadwick EG; Gibson LL; Catalina MD; McManus MM; Yogev R; Palumbo P; Sullivan JL; Britto P; Gay H; Luzuriaga K;
    J Immunol; 2001 Dec; 167(12):7134-40. PubMed ID: 11739536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.
    Panagiotakis SH; Soufla G; Baritaki S; Sourvinos G; Passam A; Zagoreos I; Stavrianeas N; Spandidos DA
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):10-8. PubMed ID: 17263627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8
    Veel E; Westera L; van Gent R; Bont L; Otto S; Ruijsink B; Rabouw HH; Mudrikova T; Wensing A; Hoepelman AIM; Borghans JAM; Tesselaar K
    Front Immunol; 2018; 9():572. PubMed ID: 29619031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort.
    Wittkop L; Bitard J; Lazaro E; Neau D; Bonnet F; Mercie P; Dupon M; Hessamfar M; Ventura M; Malvy D; Dabis F; Pellegrin JL; Moreau JF; Thiébaut R; Pellegrin I;
    J Infect Dis; 2013 Feb; 207(4):622-7. PubMed ID: 23204178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus and HIV: A Dangerous Pas de Deux.
    Gianella S; Letendre S
    J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S67-74. PubMed ID: 27625433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
    Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
    J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy.
    Ariyanto IA; Estiasari R; Waters S; Wulandari EAT; Fernandez S; Lee S; Price P
    Viral Immunol; 2018; 31(6):472-479. PubMed ID: 29688840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.
    Brunt SJ; Lee S; D'Orsogna L; Bundell C; Burrows S; Price P
    Dis Markers; 2014; 2014():947432. PubMed ID: 25506120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.